Ian Wendt

Ian Wendt has over three decades of experience in the biotechnology and pharmaceutical sectors. Ian is currently serving as the Chief Commercial Officer at an emerging biotechnology company. Prior to his current role, Ian has held leadership positions at a variety of large pharmaceutical companies leading national teams and driving market development outcomes in HIV treatment and prevention, and hepatitis C. His expertise spans business strategy, revenue and profit growth, and cross-functional leadership, making him a sought-after voice in the industry.